SCHEMBL20066897

SCHEMBL20066897

COc1ccc(N(c2ccc(OC)cc2)c2ccc3c(c2)C(c2ccccc2)(C2(c4ccccc4)c4cc(N(c5ccc(OC)cc5)c5ccc(OC)cc5)ccc4-c4ccc(N(c5ccc(OC)cc5)c5ccc(OC)cc5)cc42)c2cc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)ccc2-3)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 4/20 0.42
▸ OPRL1 P41146 4/20 0.42
▸ PDK2 Q15119 3/20 0.38
▸ CA4 P22748 1/20 0.37
▸ LTA4H P09960 2/20 0.37
▸ MAPT P10636 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ABL1 P00519 1/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ BCR P11274 1/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ RPS6KA2 Q15349 1/20 0.34
▸ PGR P06401 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20066646 0.96 PDK2 (0.41) OPRM1OPRL1PDK2CA4LTA4H
SCHEMBL21031614 0.88 OPRM1 (0.42) OPRM1OPRL1PDK2CA4LTA4H
SCHEMBL20066890 0.86 ALDH1A1 (0.41) PDK2MAPTKDM4EKMT2AMEN1
SCHEMBL12376870 0.85 CA4 (0.39) OPRM1OPRL1PDK2CA4LTA4H
SCHEMBL16996132 0.85 PDK2 (0.41) OPRM1OPRL1PDK2CA4LTA4H
SCHEMBL20066908 0.84 OPRM1 (0.33) OPRM1OPRL1ABCB1BACE1
SCHEMBL1929414 0.84 OPRM1 (0.41) OPRM1OPRL1PDK2CA4LTA4H
SCHEMBL21364231 0.83 PDK2 (0.40) OPRM1OPRL1PDK2LTA4HMAPT
SCHEMBL16996425 0.83 PDK2 (0.40) OPRM1OPRL1PDK2LTA4HMAPT
SCHEMBL17903090 0.83 OPRM1 (0.41) OPRM1OPRL1PDK2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10907093-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-02-02 — — US disclosed
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-19 — — US disclosed
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME C1S, SCO2, CCND2 OPRM1 1597/4885OPRL1 506/4885PDK2 1507/4885
US-10907093-B2 Condensed cyclic compound and organic light-emitting device including the same C1S, SCO2, CCND2 OPRM1 1597/4885OPRL1 506/4885PDK2 1507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback